JP2001508761A - 皮膚コンディションの改善方法 - Google Patents
皮膚コンディションの改善方法Info
- Publication number
- JP2001508761A JP2001508761A JP54246197A JP54246197A JP2001508761A JP 2001508761 A JP2001508761 A JP 2001508761A JP 54246197 A JP54246197 A JP 54246197A JP 54246197 A JP54246197 A JP 54246197A JP 2001508761 A JP2001508761 A JP 2001508761A
- Authority
- JP
- Japan
- Prior art keywords
- support layer
- skin
- wekroma
- magnetic vector
- potential field
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 claims abstract description 38
- 102000008186 Collagen Human genes 0.000 claims description 35
- 108010035532 Collagen Proteins 0.000 claims description 35
- 229920001436 collagen Polymers 0.000 claims description 35
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 27
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 14
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 12
- 239000011780 sodium chloride Substances 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 7
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 6
- 239000004973 liquid crystal related substance Substances 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 4
- 239000007789 gas Substances 0.000 claims description 3
- 230000006872 improvement Effects 0.000 claims description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 3
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 claims description 2
- 229910001424 calcium ion Inorganic materials 0.000 claims description 2
- 229910052742 iron Inorganic materials 0.000 claims description 2
- -1 iron ions Chemical class 0.000 claims description 2
- 239000007791 liquid phase Substances 0.000 claims 6
- 239000012071 phase Substances 0.000 claims 2
- 239000000243 solution Substances 0.000 description 23
- 229910052500 inorganic mineral Inorganic materials 0.000 description 20
- 239000011707 mineral Substances 0.000 description 20
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 19
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 19
- 210000003491 skin Anatomy 0.000 description 16
- 102000004169 proteins and genes Human genes 0.000 description 13
- 108090000623 proteins and genes Proteins 0.000 description 13
- 239000012266 salt solution Substances 0.000 description 13
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 239000000523 sample Substances 0.000 description 12
- 238000012360 testing method Methods 0.000 description 10
- 238000011282 treatment Methods 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 9
- 210000002950 fibroblast Anatomy 0.000 description 8
- 230000037319 collagen production Effects 0.000 description 7
- 230000001632 homeopathic effect Effects 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 230000002500 effect on skin Effects 0.000 description 5
- 238000012423 maintenance Methods 0.000 description 5
- 239000002953 phosphate buffered saline Substances 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 102000016942 Elastin Human genes 0.000 description 4
- 108010014258 Elastin Proteins 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 229920002549 elastin Polymers 0.000 description 4
- 238000010348 incorporation Methods 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 239000012488 sample solution Substances 0.000 description 4
- 238000003556 assay Methods 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 239000008367 deionised water Substances 0.000 description 3
- 229910021641 deionized water Inorganic materials 0.000 description 3
- 210000004207 dermis Anatomy 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 102000012422 Collagen Type I Human genes 0.000 description 2
- 108010022452 Collagen Type I Proteins 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 229920002683 Glycosaminoglycan Polymers 0.000 description 2
- 240000001140 Mimosa pudica Species 0.000 description 2
- 235000016462 Mimosa pudica Nutrition 0.000 description 2
- 102000004887 Transforming Growth Factor beta Human genes 0.000 description 2
- 108090001012 Transforming Growth Factor beta Proteins 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- ZLCOWUKVVFVVKA-WDSKDSINSA-N (2r)-3-[[(2r)-2-acetamido-2-carboxyethyl]disulfanyl]-2-aminopropanoic acid Chemical compound CC(=O)N[C@H](C(O)=O)CSSC[C@H](N)C(O)=O ZLCOWUKVVFVVKA-WDSKDSINSA-N 0.000 description 1
- XZKIHKMTEMTJQX-UHFFFAOYSA-N 4-Nitrophenyl Phosphate Chemical compound OP(O)(=O)OC1=CC=C([N+]([O-])=O)C=C1 XZKIHKMTEMTJQX-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 235000011468 Albizia julibrissin Nutrition 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 208000035484 Cellulite Diseases 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 208000001126 Keratosis Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 241001070944 Mimosa Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 206010049752 Peau d'orange Diseases 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- 206010064127 Solar lentigo Diseases 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 230000036232 cellulite Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- 206010021198 ichthyosis Diseases 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 230000037312 oily skin Effects 0.000 description 1
- 238000003359 percent control normalization Methods 0.000 description 1
- INAAIJLSXJJHOZ-UHFFFAOYSA-N pibenzimol Chemical compound C1CN(C)CCN1C1=CC=C(N=C(N2)C=3C=C4NC(=NC4=CC=3)C=3C=CC(O)=CC=3)C2=C1 INAAIJLSXJJHOZ-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 235000011962 puddings Nutrition 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/83—Electrophoresis; Electrodes; Electrolytic phenomena
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/87—Application Devices; Containers; Packaging
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Radiology & Medical Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Lasers (AREA)
- Fats And Perfumes (AREA)
- Apparatuses For Bulk Treatment Of Fruits And Vegetables And Apparatuses For Preparing Feeds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/646,798 US5905265A (en) | 1996-05-21 | 1996-05-21 | Method of improving skin condition |
| US08/646,798 | 1996-05-21 | ||
| PCT/US1997/007936 WO1997044810A1 (en) | 1996-05-21 | 1997-05-13 | Method of improving skin condition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2001508761A true JP2001508761A (ja) | 2001-07-03 |
Family
ID=24594498
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP54246197A Pending JP2001508761A (ja) | 1996-05-21 | 1997-05-13 | 皮膚コンディションの改善方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US5905265A (https=) |
| JP (1) | JP2001508761A (https=) |
| KR (1) | KR100450713B1 (https=) |
| CN (1) | CN1123050C (https=) |
| AR (1) | AR048562A1 (https=) |
| AU (1) | AU708049B2 (https=) |
| CA (1) | CA2256348C (https=) |
| CO (1) | CO4850561A1 (https=) |
| IL (1) | IL127182A0 (https=) |
| IN (1) | IN183686B (https=) |
| TW (2) | TWI272635B (https=) |
| WO (1) | WO1997044810A1 (https=) |
| ZA (1) | ZA974421B (https=) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003137807A (ja) * | 2001-11-01 | 2003-05-14 | Miyagi Kagaku Kogyo Kk | コラーゲン産生促進剤、それを含む化粧品、食品および医薬品ならびに皮膚疾患の予防または改善用外用剤 |
| JP2007039397A (ja) * | 2005-08-04 | 2007-02-15 | Sapporo Breweries Ltd | ビール酵母で発酵させたアルコール飲料からコラーゲン産生促進作用を有する組成物を製造する方法及びその組成物 |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE217302T1 (de) | 1998-07-27 | 2002-05-15 | John Nikolaj Hvarre | Vorrichtung und aufbereitung zur behandlung von leitungswasser und trinkwasser |
| US6290993B1 (en) * | 1999-07-23 | 2001-09-18 | E-L Management Corp. | Compositions containing mimosa phenolic compounds |
| DE10223221A1 (de) * | 2002-05-24 | 2003-12-11 | Sebapharma Gmbh & Co Kg | Kosmetische Zusammensetzung mit hautentquellender Wirkung |
| JP2004167467A (ja) * | 2002-11-15 | 2004-06-17 | Lidic Inc | 振動情報記録水 |
| GR1004816B (el) * | 2003-05-07 | 2005-02-18 | Evalion Ανωνυμη Εταιρεια Παροχης Υπηρεσιων-Συμβουλευτικη-Εμπορικη | Μεθοδος μεταφορας συχνοτητων σε ουσιες μεσω κρυσταλλων και παρασκευη σκευασματων τα οποια περιεχουν τις συχνοτητες αυτες |
| JP2004337831A (ja) * | 2003-05-16 | 2004-12-02 | Lidic Inc | 生体の生命力を支援する振動情報の生成方法 |
| US20100181261A1 (en) * | 2009-01-22 | 2010-07-22 | Eagle Research LLC | Aqueous environment treatment apparatus and method |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3612315A1 (de) * | 1986-04-11 | 1987-10-22 | Kropp Werner | Substrat und verfahren sowie vorrichtung zu seiner herstellung |
| CA2086124C (en) * | 1990-07-06 | 2002-04-16 | Jack E. Bridges | Method and apparatus for rendering medical materials safe |
| US5247179A (en) * | 1990-10-18 | 1993-09-21 | Hiroshi Tachibana | Activation energy providing device |
-
1996
- 1996-05-21 US US08/646,798 patent/US5905265A/en not_active Expired - Fee Related
-
1997
- 1997-05-13 CA CA002256348A patent/CA2256348C/en not_active Expired - Fee Related
- 1997-05-13 JP JP54246197A patent/JP2001508761A/ja active Pending
- 1997-05-13 KR KR10-1998-0709302A patent/KR100450713B1/ko not_active Expired - Fee Related
- 1997-05-13 IL IL12718297A patent/IL127182A0/xx unknown
- 1997-05-13 WO PCT/US1997/007936 patent/WO1997044810A1/en not_active Ceased
- 1997-05-13 AU AU30028/97A patent/AU708049B2/en not_active Ceased
- 1997-05-13 CN CN97196632A patent/CN1123050C/zh not_active Expired - Fee Related
- 1997-05-20 AR ARP970102131A patent/AR048562A1/es unknown
- 1997-05-21 ZA ZA9704421A patent/ZA974421B/xx unknown
- 1997-05-21 TW TW090102193A patent/TWI272635B/zh not_active IP Right Cessation
- 1997-05-21 IN IN1083MA1997 patent/IN183686B/en unknown
- 1997-05-21 CO CO97027714A patent/CO4850561A1/es unknown
- 1997-05-21 TW TW086106812A patent/TW483020B/zh not_active IP Right Cessation
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003137807A (ja) * | 2001-11-01 | 2003-05-14 | Miyagi Kagaku Kogyo Kk | コラーゲン産生促進剤、それを含む化粧品、食品および医薬品ならびに皮膚疾患の予防または改善用外用剤 |
| JP2007039397A (ja) * | 2005-08-04 | 2007-02-15 | Sapporo Breweries Ltd | ビール酵母で発酵させたアルコール飲料からコラーゲン産生促進作用を有する組成物を製造する方法及びその組成物 |
Also Published As
| Publication number | Publication date |
|---|---|
| AR048562A1 (es) | 2006-05-10 |
| CA2256348A1 (en) | 1997-11-27 |
| CO4850561A1 (es) | 1999-10-26 |
| US5905265A (en) | 1999-05-18 |
| AU708049B2 (en) | 1999-07-29 |
| TW483020B (en) | 2002-04-11 |
| KR100450713B1 (ko) | 2004-12-03 |
| CA2256348C (en) | 2002-07-23 |
| CN1226338A (zh) | 1999-08-18 |
| IN183686B (https=) | 2000-03-18 |
| WO1997044810A1 (en) | 1997-11-27 |
| TWI272635B (en) | 2007-02-01 |
| ZA974421B (en) | 1997-12-22 |
| AU3002897A (en) | 1997-12-09 |
| CN1123050C (zh) | 2003-10-01 |
| KR20000011142A (ko) | 2000-02-25 |
| IL127182A0 (en) | 1999-09-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Freitas et al. | The effect of Phyllanthus niruri on urinary inhibitors of calcium oxalate crystallization and other factors associated with renal stone formation | |
| Gamble et al. | Regulation of human monocyte adherence by granulocyte-macrophage colony-stimulating factor. | |
| JP2002502413A (ja) | 創傷治療のための部材及び方法 | |
| JPH0441413A (ja) | 毛髪改質剤 | |
| JP2001508761A (ja) | 皮膚コンディションの改善方法 | |
| CN115444778A (zh) | 包含山柰酚糖苷化合物的皮肤保护用组合物 | |
| Strunk et al. | Human peripheral blood monocyte-derived macrophages produce haemolytically active C3 in vitro | |
| Shimojo et al. | Identification and characterization of a tissue kallikrein in rat skeletal muscles | |
| JP2021080271A (ja) | 転移を阻害し、線維症を処置し、かつ創傷の治癒を向上させる方法および組成物 | |
| ULLAH et al. | Exotoxic substances produced by Edwardsiella tarda | |
| Philpott et al. | Improved selective cytotoxicity with an antibody-diphtheria toxin conjugate | |
| MD1521F2 (en) | Methods of thrombus forming inhibition, methods of treatment of thrombotic states, pharmaceutical compositions and kit for treatment of thrombotic states | |
| Muzykantov et al. | Target-sensitive immunoerythrocytes: interaction of biotinylated red blood cells with immobilized avidin induces their lysis by complement | |
| JPH06508111A (ja) | 甲状腺由来の軟骨細胞刺激因子 | |
| Litin et al. | Effect of D, L‐penicillamine on the urinary excretion of copper and calcium in hepatolenticular degeneration (Wilson's disease) | |
| CN102379917A (zh) | 应用豆类产品治疗和预防放疗引起的皮肤损伤 | |
| JPH10147515A (ja) | 皮膚外用剤 | |
| Storm et al. | Natural thermal resistance of human tumor cells and the role of prostaglandin | |
| CA1052696A (en) | Preparations for treatment of acne vulgaris | |
| KR102497294B1 (ko) | 신규 펩타이드를 유효성분으로 포함하는 피부 질환 예방 및 개선용 피부 외용제 조성물 | |
| Opalińska-Kubowicz et al. | How obesity impacts the skin microbiome-Literature review | |
| Tseng et al. | Through Modulation of the M2 Macrophage Subpopulation | |
| RU2246948C2 (ru) | Способ лечения больных с затяжной пневмонией | |
| CN116262098A (zh) | 一种皮肤抗衰修复组合物及包含其的多层脂质纳米粒 | |
| KR20000024460A (ko) | 복합항원체를 이용한 계란복합항체의 생산 및 피부질환치료용 조성물 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20050614 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20050908 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20051024 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20051214 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20070320 |
|
| A72 | Notification of change in name of applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A721 Effective date: 20070615 |